IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma

Journal of Craniofacial Surgery

Volumn 22, Issue 6, 2011, Pages 2022-2025

  Li, Hai Gang ^a   Han, Jing Jing ^a   Huang, Zhi Quan ^a   Wang, Lin ^a   Chen, Wei Liang ^a   Shen, Xi Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

IMP3; metastasis; prognosis; Tongue squamous cell carcinoma

Indexed keywords

IMP3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LEUKOPLAKIA; MALE; METASTASIS; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; STATISTICS, NONPARAMETRIC; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 82955237543     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3182319750     Document Type: Article

References (28)

1. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195-215
2. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002;112:616-625
3. Laimer K, Fong D, Gastl G, et al. EpCAM expression in squamous cell carcinoma of the oral cavity: Frequency and relationship to clinicopathologic features. Oral Oncol 2008;44:72-77
4. Runge S, Nielsen FC, Nielsen J, et al. H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem 2000;275:29562-29569
5. Doyle GA, Betz NA, Leeds PF, et al. The c-myc coding region determinant-binding protein: A member of a family of KH domain RNA-binding proteins. Nucleic Acids Res 1998;26:5036-5044
6. Liao B, Hu Y, Herrick DJ, et al. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005;280:18517-18524
7. Nielsen J, Christiansen J, Lykke-Andersen J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;9:1262-1270
8. Mueller-Pillasch F, Pohl B, Wilda M, et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999;88:95-99
9. Gress TM, Muller-Pillasch F, Geng M, et al. A pancreatic cancer-specific expression profile. Oncogene 1996;13:1819-1830
10. Wang T, Hopkins D, Schmidt C, et al. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 2000;19:1519-1528
11. Hoffmann NE, Sheinin Y, Lohse CM, et al. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 2008;112:1471-1479
12. Wang T, Fan L, Watanabe Y, et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003;88:887-894
13. Yantiss PK, Woda BA, Fanger GR, et al. KOC (K homology domain containing protein overexpressed in cancer): A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005;29:188-195
14. Jiang Z, Chu P, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: A retrospective study. Lancet Oncol 2006;7:556-564
15. Li C, Rock KL, Woda BA, et al. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: An immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007;20:242-247
16. Li C, Zota V, Woda BA, et al. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: Diagnostic significance and clinicopathologic correlations. Mod Pathol 2007;20:1263-1268
17. Hammer NA, Hansen TO, Byskov AG, et al. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. Reproduction 2005;130:203-212
18. Zavras AI, Pitiphat W, Wu T, et al. Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res 2003;63:296-297
19. Murrell A, Heeson S, CooperWN, et al. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: Interaction between genotype and epigenotype. Hum Mol Genet 2004;13:247-255
20. Eggenschwiler J, Ludwig T, Fisher P, et al. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 1997;11:3128-3142
21. Sun FL, Dean WL, Kelsey G, et al. Transactivation of IGF2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 1997;389:809-815
22. Kuribayashi Y, Morita K, Tomioka H, et al. Gene expression analysis by oligonucleotide microarray in oral leukoplakia. J Oral Pathol Med 2009;38:356-361
23. Riener MO, Fritzsche FR, Clavien PA, et al. IMP3 expression in lesions of the biliary tract: A marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. Hum Pathol 2009;40:1377-1383
24. Lu D, Vohra P, Chu PG, et al. An oncofetal protein IMP3: A new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia. Am J Surg Pathol 2009;33:521-525
25. Yuan RH, Wang CC, Chou CC, et al. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009;16:1711-1719
26. Vikesaa J, Hansen TV, Jonson L, et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBOJ 2006;25:1456-1468
27. Yaniv K, Fainsod A, Kalcheim C, et al. The RNA-binding protein Vg1 RBP is required for cell migration during early neural development. Development 2003;130:5649-5661
28. Jeng YM, Chang CC, Hu FC, et al. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008;48:1118-1127